| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear receptor binding SET domain protein 2 | 0.507 | 0.769 | 1.00 |
|
phenotype | 0.400 | strong | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
enoyl-CoA hydratase, short chain 1 | 0.601 | 0.654 | 8.8E-04 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2014 | 2018 | ||||||||
|
hypoxanthine phosphoribosyltransferase 1 | 0.500 | 0.808 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2014 | 2015 | ||||||||
|
beta-1,3-N-acetylgalactosaminyltransferase 2 | 0.578 | 0.577 | 2.8E-07 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2013 | 2014 | ||||||||
|
SRY-box transcription factor 5 | 0.545 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2017 | ||||||||
|
TBL1X receptor 1 | 0.534 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2017 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2014 | ||||||||
|
thyroid hormone receptor alpha | 0.566 | 0.769 | 0.33 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2016 | ||||||||
|
acylglycerol kinase | 0.650 | 0.654 | 6.0E-09 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2017 | ||||||||
|
solute carrier family 52 member 2 | 0.483 | 0.808 | 2.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2016 | ||||||||
|
solute carrier family 52 member 3 | 0.610 | 0.654 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2016 | ||||||||
|
ATPase phospholipid transporting 8A2 | 0.659 | 0.577 | 1.2E-12 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2012 | 2017 | ||||||||
|
kinesin family member 1A | 0.559 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2011 | 2018 | ||||||||
|
ciliogenesis and planar polarity effector 1 | 0.575 | 0.692 | 5.9E-36 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2011 | 2015 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
transmembrane and coiled-coil domains 1 | 0.588 | 0.654 | 9.4E-10 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2010 | 2014 | ||||||||
|
DEAF1 transcription factor | 0.575 | 0.615 | 3.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2010 | 2017 | ||||||||
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B | 0.527 | 0.769 | 2.4E-03 |
|
phenotype | 0.400 | None | 1.000 | 0 | 0 | 2009 | 2009 | ||||||||
|
coiled-coil and C2 domain containing 2A | 0.532 | 0.692 | 1.7E-27 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2009 | 2017 | ||||||||
|
protocadherin 19 | 0.599 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2008 | 2017 | ||||||||
|
CCCTC-binding factor | 0.504 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2008 | 2017 | ||||||||
|
mitochondrial ribosomal protein S22 | 0.638 | 0.500 | 1.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2007 | 2017 | ||||||||
|
solute carrier family 25 member 3 | 0.566 | 0.692 | 7.5E-02 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
3-hydroxyisobutyryl-CoA hydrolase | 0.700 | 0.500 | 2.6E-13 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2007 | 2015 | ||||||||
|
myocyte enhancer factor 2C | 0.517 | 0.769 | 1.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 0 | 0 | 2007 | 2016 |